Latest Articles
- Diagnostic & Treatment ChallengesMOG Antibody–Associated Disease and Thymic HyperplasiaFrom the National Multiple Sclerosis Society Case Conference ProceedingsBrigitte Hurtubise, Elliot M. Frohman, Steven Galetta, et al.December 14, 2022
- Research ArticlemiRNA Signature in CSF From Patients With Primary Progressive Multiple SclerosisMaría Muñoz-San Martín, Imma Gómez, Ana Quiroga-Varela, et al.December 09, 2022
- Research ArticleLong-term Efficacy of Satralizumab in AQP4-IgG–Seropositive Neuromyelitis Optica Spectrum Disorder From SAkuraSky and SAkuraStarIngo Kleiter, Anthony Traboulsee, Jacqueline Palace, et al.December 08, 2022
- Research ArticleNeuroinflammation-Related Proteins NOD2 and Spp1 Are Abnormally Upregulated in Amyotrophic Lateral SclerosisNoemí de Luna, Álvaro Carbayo, Oriol Dols-Icardo, et al.December 02, 2022
- Research ArticleSingle-Cell Transcriptomics Identifies Brain Endothelium Inflammatory Networks in Experimental Autoimmune EncephalomyelitisAntoine Philippe Fournier, Olivier Tastet, Marc Charabati, et al.November 29, 2022
- Research ArticleEarly Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGADMargherita Nosadini, Michael Eyre, Thea Giacomini, et al.November 29, 2022
- Research ArticleAnti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint InhibitorsAntonio Farina, Macarena Villagrán-García, Nicolás Lundahl Ciano-Petersen, et al.November 29, 2022
- Research ArticleAssociation of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple SclerosisEleni S. Vasileiou, Chen Hu, Charles N. Bernstein, et al.November 23, 2022
- ReviewSecondary Progressive Multiple SclerosisA Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying TherapiesTjalf Ziemssen, Virender Bhan, Jeremy Chataway, et al.November 22, 2022
- Research ArticleMore Efficient Complement Activation by Anti–Aquaporin-4 Compared With Anti–Myelin Oligodendrocyte Glycoprotein AntibodiesMagdalena Lerch, Kathrin Schanda, Eliott Lafon, et al.November 22, 2022
Pages
Advertisement
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease
Dr. Rizwan S. Akhtar and Dr. Sarah Brooker